SlideShare a Scribd company logo
1
The author has no potential
conflict of interest to disclose
2
Modificazioni Vitreo-Retiniche negli
Stafilomi nel Miope Elevato ed Eventuali
Indicazioni Chirurgiche.
Guido Ripandelli
Tommaso Rossi*
Fabio Scarinci
Mario Stirpe
IRCCS – Fondazione Bietti, Roma
*Ospedale Oftalmico, Roma
3
Macular Vitreo-Retinal Interface
Abnormalities in Highly Myopic Eyes with
Posterior Staphyloma:
5-Years Follow-Up.
Guido Ripandelli, Tommaso Rossi, * Fabio Scarinci,
Cecilia Scassa, Vincenzo Parisi, Mario Stirpe.
Retina 2012;32:1531-8.
4
• Purpose: to review prevalence, long-term
progression and prognosis of VR interface
modifications in highly myopic eyes with
posterior staphyloma
When surgery is necessary?
Which is the best timing for surgery?
• Study design: retrospective, single
Institution series
5
Patients’ characteristics
• December 1999 - December 2004
• 408 phakic eyes / 204 subjects
• 108 Males / 96 Females
• Age 22-58 years
• Myopia 18-30 D and PS (Axial lenght 30-34
mm)
6
Inclusion Criteria
• AL > 30 mm
• Presence of posterior staphyloma
• Availability of OCT, MP1 at baseline, at
latest examination, (before and after
surgery)
7
Exclusion Criteria
Patients with incomplete charts, lost at follow-
up, with significant media opacities, with
previous ocular surgery
8
Characteristics of patients
with VR changes
• Prevalence of posterior VR changes: 236/408 (57.8%) eyes
• Minimum follow-up: 5 years
• Lost to follow-up: 22/236 eyes (9.3%)
• Included in the study: 214 eyes (116 subjects)
– Bilateral VR changes 98/116 (84.4%)
– 54 males /62 females
– Age 24-59 years
– Myopia 19-30 D (29.5-34 mm)
– 209 eyes: visual acuity 20/50-20/20
– 5 eyes: C F – 20/100
9
Testing
• Visual acuity (VA)
• Biomicroscopy
• Optical Coherence Tomography (OCT)
• MP1 Microperimetry
• A, B-scan ultrasound
10
Group 1 Epiretinal membrane without retinal changes (EM) : 98 eyes
Group 2 Macular schisis with/without epiretinal membrane (MSEM): 54 eyes
Asymptomatic macular schisis with EM (AMSEM, 33 eyes)
Symptomatic macular schisis with EM (SMSEM, 14 eyes)
Posterior stretch schisis (PSS, 7 eyes)
Group 3 Partial thickness macular hole (PTMH): 24 eyes
PTHM with retinal schisis (15 eyes)
PTHM without retinal schisis (9 eyes)
Group 4 Full thickness macular hole (FTMH): 18 eyes
Asymptomatic full thickness macular hole (AFTMH, 9 eyes)
Symptomatic full thickness macular hole (SFTMH, 9 eyes)
Group 5 Posterior retinal detachment (PRD): 20 eyes
PRD with macula on (PRD M-on, 11 eyes)
PRD with macula off (PRD M-off, 4 eyes)
PRD with macular hole (PRDMH, 5 eyes)
11
Gr. 1 Epiretinal membrane without
retinal changes (EM)
98 eyes (45.7%)
12
Gr. 2 Macular schisis with/without epiretinal membrane
(MSEM, 54 eyes)
Asymptomatic macular schisis with epiretinal membrane (AMSEM)
33 eyes (15.4%)
13
Symptomatic macular schisis with epiretinal membrane (SMSEM)
14 eyes (6.5%)
Gr. 2 Macular schisis with/without epiretinal membrane
(MSEM, 54 eyes)
14
Posterior stretch schisis (PSS)
7 eyes (3.3%)
Gr. 2 Macular schisis with/without epiretinal membrane
(MSEM, 54 eyes)
15
Gr. 3 Partial thickness macular hole ( PTMH, 24 eyes)
PTMH with macular schisis
15 eyes (7%)
16
Gr. 3 Partial thickness macular hole ( PTMH, 24 eyes)
PTMH without macular schisis
9 eyes (4.2%)
17
Asymptomatic full thickness macular hole (AFTMH)
9 eyes (4.2%)
Gr. 4 Full thickness macular hole ( FTMH, 18 eyes)
18
Symptomatic full thickness macular hole (SFTMH)
9 eyes (4.2%)
Gr. 4 Full thickness macular hole ( FTMH, 18 eyes)
19
PRD in the staphyloma area with macula on (PRD M-on)
11 eyes (5.1%)
Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
20
PRD in the staphyloma area with macula off (PRD M-off)
4 eyes (1.8%)
Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
21
PRD with macular hole (PRDMH)
5 eyes (2.3%)
Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
22
Evolution to pathologies requiring surgery: 24/205 (11.7%)
(9 PRD eyes underwent surgery upon presentation)
Gr. 1 Epiretinal membrane without retinal changes (EM) : 2/98 (2V)
Gr. 2 Asymptomatic macular schisis (AMSEM): 6/33 (3V, 3V+PB)
Symptomatic macular schisis (SMSEM): 7/14 (4V, 3V+PB)
Posterior stretch schisis (PSS): 0/7 -
Gr. 3 PTHM with macular schisis (PTMH-MS): 5/15 (3V, 2V+PB)
PTMH without macular schisis (PTMH-w/o MS): 0/9 -
Gr. 4 Asymptomatic macular hole (AFTMH): 2/9 (2V)
Symptomatic macular hole (SFTMH): 1/9 (1V)
Gr. 5 PRD in staphyloma area / macula ON (PRD M-on): 1/11 (1V)
PRD in staphyloma area/ macula off (PRD M-off): 4/4 (2V, 2V+PB)
PRD with macular hole (PRD-MH): 5/5 (2V, 3V+PB)
V= vitrectomy, PB= posterior buckle
23
Observations
High myopia with posterior staphyloma
can be associated with a broad
spectrum of vitreoretinal alterations
and represents an elusive nosological
entity, whose natural history,
progression, therapeutic options and
surgical timing remain uncertain.
24
Observations
• High myopic eyes with posterior staphyloma
show high frequency of vitreoretinal alterations
(57.8%)
• Bilateral vitreoretinal changes on 84.5% patients
• Anatomical changes and visual acuity remain in
most cases unchanged over time
• In evolutive cases the evolution is quite slow
• OCT and MP1 fundamental exams for diagnosing
and follow-up
25
Observations
• Microperimetry provides important data for a
timely surgical decision
• Foveal sensitivity decrease and worsening of
fixation stability are significantly associated to
the need for surgery.
26
Observations
• The decrease of sensitivity explored by MP1 is
a sign that may precede the objective
worsening of visual acuity
VA 20/25 VA 20/25
27
•Surgical removal of ER tissue represents the first
attempt to resolve the pathology
Observations
28
• The reduction of posterior staphyloma by means of
posterior buckle is a method to use to repair the
unsuccessfull cases
Observations
29
Observations
Vitreoretinal interface alterations in
highly myopic eyes have not been
univocally classified yet and the
concept itself of disease progression
and surgical indication are largely
debatable and deserve
standardization.
30
Observations
Foveal sensitivity and fixation patterns
are associated to a variable risk of
progression and visual prognosis differs
significantly among groups. We believe
this variability represents underlying
separate pathologies that warrant
diversified treatment.

More Related Content

Similar to Ripandelli the author has no potential

MANAGEMENT OF DIABETIC MACULOPATHY
MANAGEMENT OF DIABETIC MACULOPATHYMANAGEMENT OF DIABETIC MACULOPATHY
MANAGEMENT OF DIABETIC MACULOPATHY
Smith Snehal Sute
 
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
inventionjournals
 
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptxLaporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
BaqirEmil
 
Corporate presentation-20141120
Corporate presentation-20141120Corporate presentation-20141120
Corporate presentation-20141120
John Redaelli
 
Work-up of Refractive surgeries
Work-up of Refractive surgeriesWork-up of Refractive surgeries
Work-up of Refractive surgeries
ShreyaGupta323
 
Rubinstein taybi syndrome
Rubinstein taybi syndromeRubinstein taybi syndrome
Rubinstein taybi syndrome
Md Afzal Mahfuzullah
 
Bandello pharmacological treatment of vitreo macular traction
Bandello pharmacological treatment of vitreo macular tractionBandello pharmacological treatment of vitreo macular traction
Bandello pharmacological treatment of vitreo macular traction
Thessaloniki International Vitreo-Retinal Summer School
 
Pigmentary glaucoma - Dr Shylesh B Dabke
Pigmentary glaucoma - Dr Shylesh B DabkePigmentary glaucoma - Dr Shylesh B Dabke
Pigmentary glaucoma - Dr Shylesh B Dabke
Shylesh Dabke
 
Robotic Radiosurgery Treatment for Eye Tumours
Robotic Radiosurgery Treatment for Eye Tumours  Robotic Radiosurgery Treatment for Eye Tumours
Robotic Radiosurgery Treatment for Eye Tumours
duttaradio
 
Corporate presentation 20141112 (1)
Corporate presentation 20141112 (1)Corporate presentation 20141112 (1)
Corporate presentation 20141112 (1)
John Redaelli
 
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
DrAyushiAgarwal
 
Pathological myopia 01.03.2014
Pathological myopia 01.03.2014Pathological myopia 01.03.2014
Pathological myopia 01.03.2014
Mohammad Bawtag
 
Ospe 21 march 2017
Ospe 21 march 2017Ospe 21 march 2017
Ospe 21 march 2017
Anisur Rahman
 
macular hole.pptx
macular hole.pptxmacular hole.pptx
macular hole.pptx
AllAboutECG
 
Pathological Myopia.pptx
Pathological Myopia.pptxPathological Myopia.pptx
Pathological Myopia.pptx
Mohammad Bawtag
 
MACULAR HOLE.pptx
MACULAR HOLE.pptxMACULAR HOLE.pptx
MACULAR HOLE.pptx
SwatiRamteke7
 
Retinoblastoma case presentation, final
Retinoblastoma  case presentation, finalRetinoblastoma  case presentation, final
Retinoblastoma case presentation, final
priyanka singh
 
Sw sn
Sw snSw sn
Optic neuritis & Multiple Sclerosis (2018)
Optic neuritis & Multiple Sclerosis (2018)Optic neuritis & Multiple Sclerosis (2018)
Optic neuritis & Multiple Sclerosis (2018)
University Malaya, Malaysia
 
Case Report and Clinical Findings of Central Serous Retinopathy
Case Report and Clinical Findings of Central Serous RetinopathyCase Report and Clinical Findings of Central Serous Retinopathy
Case Report and Clinical Findings of Central Serous Retinopathy
Dan Mulder
 

Similar to Ripandelli the author has no potential (20)

MANAGEMENT OF DIABETIC MACULOPATHY
MANAGEMENT OF DIABETIC MACULOPATHYMANAGEMENT OF DIABETIC MACULOPATHY
MANAGEMENT OF DIABETIC MACULOPATHY
 
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
A Variety of Anatomical and Clinical Manifestations of Myelinated Retinal Ner...
 
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptxLaporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
Laporan Kasus Corneal Distrophy-Muhammad Baqir IIM.pptx
 
Corporate presentation-20141120
Corporate presentation-20141120Corporate presentation-20141120
Corporate presentation-20141120
 
Work-up of Refractive surgeries
Work-up of Refractive surgeriesWork-up of Refractive surgeries
Work-up of Refractive surgeries
 
Rubinstein taybi syndrome
Rubinstein taybi syndromeRubinstein taybi syndrome
Rubinstein taybi syndrome
 
Bandello pharmacological treatment of vitreo macular traction
Bandello pharmacological treatment of vitreo macular tractionBandello pharmacological treatment of vitreo macular traction
Bandello pharmacological treatment of vitreo macular traction
 
Pigmentary glaucoma - Dr Shylesh B Dabke
Pigmentary glaucoma - Dr Shylesh B DabkePigmentary glaucoma - Dr Shylesh B Dabke
Pigmentary glaucoma - Dr Shylesh B Dabke
 
Robotic Radiosurgery Treatment for Eye Tumours
Robotic Radiosurgery Treatment for Eye Tumours  Robotic Radiosurgery Treatment for Eye Tumours
Robotic Radiosurgery Treatment for Eye Tumours
 
Corporate presentation 20141112 (1)
Corporate presentation 20141112 (1)Corporate presentation 20141112 (1)
Corporate presentation 20141112 (1)
 
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
Blepharophimosis Ptosis Epicanthus inversus Syndrome (BPES)
 
Pathological myopia 01.03.2014
Pathological myopia 01.03.2014Pathological myopia 01.03.2014
Pathological myopia 01.03.2014
 
Ospe 21 march 2017
Ospe 21 march 2017Ospe 21 march 2017
Ospe 21 march 2017
 
macular hole.pptx
macular hole.pptxmacular hole.pptx
macular hole.pptx
 
Pathological Myopia.pptx
Pathological Myopia.pptxPathological Myopia.pptx
Pathological Myopia.pptx
 
MACULAR HOLE.pptx
MACULAR HOLE.pptxMACULAR HOLE.pptx
MACULAR HOLE.pptx
 
Retinoblastoma case presentation, final
Retinoblastoma  case presentation, finalRetinoblastoma  case presentation, final
Retinoblastoma case presentation, final
 
Sw sn
Sw snSw sn
Sw sn
 
Optic neuritis & Multiple Sclerosis (2018)
Optic neuritis & Multiple Sclerosis (2018)Optic neuritis & Multiple Sclerosis (2018)
Optic neuritis & Multiple Sclerosis (2018)
 
Case Report and Clinical Findings of Central Serous Retinopathy
Case Report and Clinical Findings of Central Serous RetinopathyCase Report and Clinical Findings of Central Serous Retinopathy
Case Report and Clinical Findings of Central Serous Retinopathy
 

More from Thessaloniki International Vitreo-Retinal Summer School

Ripandelli posterior buckling for macular hole
Ripandelli posterior buckling for macular holeRipandelli posterior buckling for macular hole
Ripandelli posterior buckling for macular hole
Thessaloniki International Vitreo-Retinal Summer School
 
Reppucci retinotmoy resection tvrs
Reppucci retinotmoy resection tvrsReppucci retinotmoy resection tvrs
Zografos tumors and pseudotumors of the optic disc
Zografos tumors and pseudotumors of the optic discZografos tumors and pseudotumors of the optic disc
Zografos tumors and pseudotumors of the optic disc
Thessaloniki International Vitreo-Retinal Summer School
 
Zografos anti veg fs in ocular oncology
Zografos  anti veg fs in ocular oncologyZografos  anti veg fs in ocular oncology
Zografos anti veg fs in ocular oncology
Thessaloniki International Vitreo-Retinal Summer School
 
Parikakis the setup of advanced vr course
Parikakis  the setup of advanced vr courseParikakis  the setup of advanced vr course
Parikakis the setup of advanced vr course
Thessaloniki International Vitreo-Retinal Summer School
 
Ovali bimanual transconjunctional virectomy
Ovali  bimanual transconjunctional virectomyOvali  bimanual transconjunctional virectomy
Ovali bimanual transconjunctional virectomy
Thessaloniki International Vitreo-Retinal Summer School
 
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular tractionNikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
Thessaloniki International Vitreo-Retinal Summer School
 
Nikolakopoulos hydrolifting in cortical vitreous attachments
Nikolakopoulos hydrolifting in  cortical vitreous attachmentsNikolakopoulos hydrolifting in  cortical vitreous attachments
Nikolakopoulos hydrolifting in cortical vitreous attachments
Thessaloniki International Vitreo-Retinal Summer School
 
Nikolakopoulos fundamentals and principals of oct
Nikolakopoulos fundamentals and principals of octNikolakopoulos fundamentals and principals of oct
Nikolakopoulos fundamentals and principals of oct
Thessaloniki International Vitreo-Retinal Summer School
 
Nikolakopoulos esaso
Nikolakopoulos esasoNikolakopoulos esaso
Nikolakopoulos esaso traction rd
Nikolakopoulos esaso traction rdNikolakopoulos esaso traction rd
Nikolakopoulos esaso hydro
Nikolakopoulos esaso hydroNikolakopoulos esaso hydro
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rdNikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
Thessaloniki International Vitreo-Retinal Summer School
 
Kranias diagnostic challenges in retinal diseases 06 20 14
Kranias  diagnostic challenges in retinal diseases 06 20 14Kranias  diagnostic challenges in retinal diseases 06 20 14
Kranias diagnostic challenges in retinal diseases 06 20 14
Thessaloniki International Vitreo-Retinal Summer School
 
Guarnaccia grecia gg giugno 2014
Guarnaccia  grecia gg giugno 2014Guarnaccia  grecia gg giugno 2014
Pournaras vitreoretinal surgical management
Pournaras vitreoretinal surgical managementPournaras vitreoretinal surgical management
Pournaras vitreoretinal surgical management
Thessaloniki International Vitreo-Retinal Summer School
 
Parikakis 1 tvr scoursepcataractcomplications 2014
Parikakis  1 tvr scoursepcataractcomplications 2014Parikakis  1 tvr scoursepcataractcomplications 2014
Parikakis 1 tvr scoursepcataractcomplications 2014
Thessaloniki International Vitreo-Retinal Summer School
 
Forlini iol gold standard quatar 2010 tiblis 12
Forlini iol gold standard quatar 2010 tiblis 12Forlini iol gold standard quatar 2010 tiblis 12
Forlini iol gold standard quatar 2010 tiblis 12
Thessaloniki International Vitreo-Retinal Summer School
 

More from Thessaloniki International Vitreo-Retinal Summer School (20)

Ripandelli posterior buckling for macular hole
Ripandelli posterior buckling for macular holeRipandelli posterior buckling for macular hole
Ripandelli posterior buckling for macular hole
 
Reppucci retinotmoy resection tvrs
Reppucci retinotmoy resection tvrsReppucci retinotmoy resection tvrs
Reppucci retinotmoy resection tvrs
 
Zografos tumors and pseudotumors of the optic disc
Zografos tumors and pseudotumors of the optic discZografos tumors and pseudotumors of the optic disc
Zografos tumors and pseudotumors of the optic disc
 
Zografos anti veg fs in ocular oncology
Zografos  anti veg fs in ocular oncologyZografos  anti veg fs in ocular oncology
Zografos anti veg fs in ocular oncology
 
Parikakis the setup of advanced vr course
Parikakis  the setup of advanced vr courseParikakis  the setup of advanced vr course
Parikakis the setup of advanced vr course
 
Ovali bimanual transconjunctional virectomy
Ovali  bimanual transconjunctional virectomyOvali  bimanual transconjunctional virectomy
Ovali bimanual transconjunctional virectomy
 
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular tractionNikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
Nikolakopoulos vitrectomy or microplasmin in dme with vitreomacular traction
 
Nikolakopoulos hydrolifting in cortical vitreous attachments
Nikolakopoulos hydrolifting in  cortical vitreous attachmentsNikolakopoulos hydrolifting in  cortical vitreous attachments
Nikolakopoulos hydrolifting in cortical vitreous attachments
 
Nikolakopoulos fundamentals and principals of oct
Nikolakopoulos fundamentals and principals of octNikolakopoulos fundamentals and principals of oct
Nikolakopoulos fundamentals and principals of oct
 
Nikolakopoulos esaso
Nikolakopoulos esasoNikolakopoulos esaso
Nikolakopoulos esaso
 
Nikolakopoulos esaso traction rd
Nikolakopoulos esaso traction rdNikolakopoulos esaso traction rd
Nikolakopoulos esaso traction rd
 
Nikolakopoulos esaso hydro
Nikolakopoulos esaso hydroNikolakopoulos esaso hydro
Nikolakopoulos esaso hydro
 
Nikolakopoulos endoscleral iol
Nikolakopoulos endoscleral iolNikolakopoulos endoscleral iol
Nikolakopoulos endoscleral iol
 
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rdNikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
Nikolakopoulos 25+ 27 g evolution in bimanual primary vitrectomy for rd
 
Kranias diagnostic challenges in retinal diseases 06 20 14
Kranias  diagnostic challenges in retinal diseases 06 20 14Kranias  diagnostic challenges in retinal diseases 06 20 14
Kranias diagnostic challenges in retinal diseases 06 20 14
 
Guarnaccia grecia gg giugno 2014
Guarnaccia  grecia gg giugno 2014Guarnaccia  grecia gg giugno 2014
Guarnaccia grecia gg giugno 2014
 
Pournaras vitreoretinal surgical management
Pournaras vitreoretinal surgical managementPournaras vitreoretinal surgical management
Pournaras vitreoretinal surgical management
 
Parikakis 1 tvr scoursepcataractcomplications 2014
Parikakis  1 tvr scoursepcataractcomplications 2014Parikakis  1 tvr scoursepcataractcomplications 2014
Parikakis 1 tvr scoursepcataractcomplications 2014
 
Forlini iol gold standard quatar 2010 tiblis 12
Forlini iol gold standard quatar 2010 tiblis 12Forlini iol gold standard quatar 2010 tiblis 12
Forlini iol gold standard quatar 2010 tiblis 12
 
Forlini human optics
Forlini human opticsForlini human optics
Forlini human optics
 

Recently uploaded

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

Ripandelli the author has no potential

  • 1. 1 The author has no potential conflict of interest to disclose
  • 2. 2 Modificazioni Vitreo-Retiniche negli Stafilomi nel Miope Elevato ed Eventuali Indicazioni Chirurgiche. Guido Ripandelli Tommaso Rossi* Fabio Scarinci Mario Stirpe IRCCS – Fondazione Bietti, Roma *Ospedale Oftalmico, Roma
  • 3. 3 Macular Vitreo-Retinal Interface Abnormalities in Highly Myopic Eyes with Posterior Staphyloma: 5-Years Follow-Up. Guido Ripandelli, Tommaso Rossi, * Fabio Scarinci, Cecilia Scassa, Vincenzo Parisi, Mario Stirpe. Retina 2012;32:1531-8.
  • 4. 4 • Purpose: to review prevalence, long-term progression and prognosis of VR interface modifications in highly myopic eyes with posterior staphyloma When surgery is necessary? Which is the best timing for surgery? • Study design: retrospective, single Institution series
  • 5. 5 Patients’ characteristics • December 1999 - December 2004 • 408 phakic eyes / 204 subjects • 108 Males / 96 Females • Age 22-58 years • Myopia 18-30 D and PS (Axial lenght 30-34 mm)
  • 6. 6 Inclusion Criteria • AL > 30 mm • Presence of posterior staphyloma • Availability of OCT, MP1 at baseline, at latest examination, (before and after surgery)
  • 7. 7 Exclusion Criteria Patients with incomplete charts, lost at follow- up, with significant media opacities, with previous ocular surgery
  • 8. 8 Characteristics of patients with VR changes • Prevalence of posterior VR changes: 236/408 (57.8%) eyes • Minimum follow-up: 5 years • Lost to follow-up: 22/236 eyes (9.3%) • Included in the study: 214 eyes (116 subjects) – Bilateral VR changes 98/116 (84.4%) – 54 males /62 females – Age 24-59 years – Myopia 19-30 D (29.5-34 mm) – 209 eyes: visual acuity 20/50-20/20 – 5 eyes: C F – 20/100
  • 9. 9 Testing • Visual acuity (VA) • Biomicroscopy • Optical Coherence Tomography (OCT) • MP1 Microperimetry • A, B-scan ultrasound
  • 10. 10 Group 1 Epiretinal membrane without retinal changes (EM) : 98 eyes Group 2 Macular schisis with/without epiretinal membrane (MSEM): 54 eyes Asymptomatic macular schisis with EM (AMSEM, 33 eyes) Symptomatic macular schisis with EM (SMSEM, 14 eyes) Posterior stretch schisis (PSS, 7 eyes) Group 3 Partial thickness macular hole (PTMH): 24 eyes PTHM with retinal schisis (15 eyes) PTHM without retinal schisis (9 eyes) Group 4 Full thickness macular hole (FTMH): 18 eyes Asymptomatic full thickness macular hole (AFTMH, 9 eyes) Symptomatic full thickness macular hole (SFTMH, 9 eyes) Group 5 Posterior retinal detachment (PRD): 20 eyes PRD with macula on (PRD M-on, 11 eyes) PRD with macula off (PRD M-off, 4 eyes) PRD with macular hole (PRDMH, 5 eyes)
  • 11. 11 Gr. 1 Epiretinal membrane without retinal changes (EM) 98 eyes (45.7%)
  • 12. 12 Gr. 2 Macular schisis with/without epiretinal membrane (MSEM, 54 eyes) Asymptomatic macular schisis with epiretinal membrane (AMSEM) 33 eyes (15.4%)
  • 13. 13 Symptomatic macular schisis with epiretinal membrane (SMSEM) 14 eyes (6.5%) Gr. 2 Macular schisis with/without epiretinal membrane (MSEM, 54 eyes)
  • 14. 14 Posterior stretch schisis (PSS) 7 eyes (3.3%) Gr. 2 Macular schisis with/without epiretinal membrane (MSEM, 54 eyes)
  • 15. 15 Gr. 3 Partial thickness macular hole ( PTMH, 24 eyes) PTMH with macular schisis 15 eyes (7%)
  • 16. 16 Gr. 3 Partial thickness macular hole ( PTMH, 24 eyes) PTMH without macular schisis 9 eyes (4.2%)
  • 17. 17 Asymptomatic full thickness macular hole (AFTMH) 9 eyes (4.2%) Gr. 4 Full thickness macular hole ( FTMH, 18 eyes)
  • 18. 18 Symptomatic full thickness macular hole (SFTMH) 9 eyes (4.2%) Gr. 4 Full thickness macular hole ( FTMH, 18 eyes)
  • 19. 19 PRD in the staphyloma area with macula on (PRD M-on) 11 eyes (5.1%) Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
  • 20. 20 PRD in the staphyloma area with macula off (PRD M-off) 4 eyes (1.8%) Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
  • 21. 21 PRD with macular hole (PRDMH) 5 eyes (2.3%) Gr. 5 Posterior retinal detachment (PRD, 20 eyes)
  • 22. 22 Evolution to pathologies requiring surgery: 24/205 (11.7%) (9 PRD eyes underwent surgery upon presentation) Gr. 1 Epiretinal membrane without retinal changes (EM) : 2/98 (2V) Gr. 2 Asymptomatic macular schisis (AMSEM): 6/33 (3V, 3V+PB) Symptomatic macular schisis (SMSEM): 7/14 (4V, 3V+PB) Posterior stretch schisis (PSS): 0/7 - Gr. 3 PTHM with macular schisis (PTMH-MS): 5/15 (3V, 2V+PB) PTMH without macular schisis (PTMH-w/o MS): 0/9 - Gr. 4 Asymptomatic macular hole (AFTMH): 2/9 (2V) Symptomatic macular hole (SFTMH): 1/9 (1V) Gr. 5 PRD in staphyloma area / macula ON (PRD M-on): 1/11 (1V) PRD in staphyloma area/ macula off (PRD M-off): 4/4 (2V, 2V+PB) PRD with macular hole (PRD-MH): 5/5 (2V, 3V+PB) V= vitrectomy, PB= posterior buckle
  • 23. 23 Observations High myopia with posterior staphyloma can be associated with a broad spectrum of vitreoretinal alterations and represents an elusive nosological entity, whose natural history, progression, therapeutic options and surgical timing remain uncertain.
  • 24. 24 Observations • High myopic eyes with posterior staphyloma show high frequency of vitreoretinal alterations (57.8%) • Bilateral vitreoretinal changes on 84.5% patients • Anatomical changes and visual acuity remain in most cases unchanged over time • In evolutive cases the evolution is quite slow • OCT and MP1 fundamental exams for diagnosing and follow-up
  • 25. 25 Observations • Microperimetry provides important data for a timely surgical decision • Foveal sensitivity decrease and worsening of fixation stability are significantly associated to the need for surgery.
  • 26. 26 Observations • The decrease of sensitivity explored by MP1 is a sign that may precede the objective worsening of visual acuity VA 20/25 VA 20/25
  • 27. 27 •Surgical removal of ER tissue represents the first attempt to resolve the pathology Observations
  • 28. 28 • The reduction of posterior staphyloma by means of posterior buckle is a method to use to repair the unsuccessfull cases Observations
  • 29. 29 Observations Vitreoretinal interface alterations in highly myopic eyes have not been univocally classified yet and the concept itself of disease progression and surgical indication are largely debatable and deserve standardization.
  • 30. 30 Observations Foveal sensitivity and fixation patterns are associated to a variable risk of progression and visual prognosis differs significantly among groups. We believe this variability represents underlying separate pathologies that warrant diversified treatment.